Pancreatic Cancer Research

ResearcherChiba Cancer Center Research InstituteNo recent work listed

Toshinori Ozaki

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-1612-7394; OpenAlex author ID A5034252509. Sources: OpenAlex.

Their work

Papers
7 (first author 0, last author 5)
Trials
0
Grants
0
Labs led
1
Collaborators
7
Papers, trials and grants by year

2015: 2 papers · 2016: 2 papers · 2017: 1 paper · 2018: 2 papers

Papers 7

  1. Impact of RUNX2 on drug-resistant human pancreatic cancer cells with p53 mutations. Co-author DOI 10.1186/s12885-018-4217-9↗
  2. Impact of RUNX2 gene silencing on the gemcitabine sensitivity of p53‑mutated pancreatic cancer MiaPaCa‑2 spheres. Last author DOI 10.3892/or.2018.6344↗
  3. Depletion of runt-related transcription factor 2 (RUNX2) enhances SAHA sensitivity of p53-mutated pancreatic cancer cells through the regulation of mutant p53 … Last author DOI 10.1371/journal.pone.0179884↗
  4. Improvement of gemcitabine sensitivity of p53-mutated pancreatic cancer MiaPaCa-2 cells by RUNX2 depletion-mediated augmentation of TAp73-dependent cell death. Last author DOI 10.1038/oncsis.2016.40↗
  5. Depletion of pro-oncogenic RUNX2 enhances gemcitabine (GEM) sensitivity of p53-mutated pancreatic cancer Panc-1 cells through the induction of pro-apoptotic TA… Co-author DOI 10.18632/oncotarget.12433↗
  6. Silencing of RUNX2 enhances gemcitabine sensitivity of p53-deficient human pancreatic cancer AsPC-1 cells through the stimulation of TAp63-mediated cell death. Last author DOI 10.1038/cddis.2015.242↗
  7. Silencing of RUNX2 enhances gemcitabine sensitivity of p53-deficient human pancreatic cancer AsPC-1 cells through the stimulation of TAp63-mediated cell death. Last author DOI 10.1038/cddiscovery.2015.10↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Mizuyo Nakamura · 6 shared papers, 2015–2018 · strength 0.38
  2. Osamu Shimozato · 6 shared papers, 2015–2018 · strength 0.38
  3. Meijie Sang · 5 shared papers, 2015–2018 · strength 0.33
  4. Meixiang Sang · 4 shared papers, 2015–2018 · strength 0.27
  5. Takehiro Ogata · 3 shared papers, 2016–2018 · strength 0.22
  6. Hirokazu Sugimoto · 3 shared papers, 2015–2016 · strength 0.15
  7. Hiroki Nagase · 2 shared papers, 2015 · strength 0.10

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.